Cuba’s clinical vaccine against lung cancer, Cimavax-EGF, the result of more than two decades of research, with satisfactory results in people with advanced stages of lung cancer, has shown achievements in studies to the American scientific community and its population. takes victory. to be done.
The Cuban Molecular Immunology Center (CIM) and Roswell Park Cancer Research Center in Buffalo, USA, joined forces a few years ago to promote drug development, facilitate access to equipment and reagents, a relationship that is not The economic blockade against Cuba remained without difficulties due to the policy, RT reported.
Biotechnology company Innovative Immunotherapy Alliance, the creation of the only joint venture between Cuba and the United States, aimed at injecting medicine into American society, giving Cuba access to equipment and reagents that are so difficult to obtain due to limitations. Tremendous measure, while America can use a drug with excellent results and prospects.
Dr Elia Nanninger, who has participated in clinical trials of a therapeutic vaccine since its inception, assured the Russian television station that the drug has two major advantages: few adverse reactions and the solution to a serious health problem on the island, such as Lung cancer.
Kellet Leon Monzon, deputy director of the Center for Molecular Immunology, said benefited patients recover from an advanced tumor cancer and may have a very short-term chance of survival under normal conditions, the newspaper says.
One of the vaccine advocates, Miguel Creus, a patient who began receiving Simvax 15 years ago when the disease was in stage four and the vaccine was in clinical trials, assures that the drug did not work. Has prolonged his life with satisfactory health condition. , and those who currently have no signs of tumor or symptoms of disease.
Despite the effects of the White House economic blockade, the cooperation between the two institutions does not stop, and Cimavax overcomes the challenges. There are currently clinical trials that combine this Cuban vaccine with other successful cancer treatments, and their effects are being studied in people at high risk or in patients in the early stages of the disease.
According to some studies, lung cancer is the third most common cancer in the US, but the deadliest. A promising respite could be this Cuban drug, which is a good example of the benefits that both countries would accrue if they had a normal relationship.
